A San Francisco investment firm that funds healthcare companies at every stage with a data-science approach. Its cancer investments include CG Oncology, ALX Oncology, Kura Oncology and the blood-test company Delfi Diagnostics.
Foresite Capital was founded in 2011 by Jim Tananbaum and is headquartered in San Francisco (Wikipedia). It describes itself as 'a multi-stage healthcare and life sciences investment firm' that uses 'a data science-driven approach to invest in companies that leverage biology and big data to transform healthcare', and also incubates companies through Foresite Labs. Its portfolio page lists current and alumni holdings including ALX Oncology, Arcus Biosciences, Aura Biosciences, CG Oncology, Cullinan Therapeutics, Corvus Pharmaceuticals, Delfi Diagnostics (early cancer detection), Karyopharm, Kura Oncology and Lyell Immunopharma; the homepage quotes Theseus Pharmaceuticals on 'our mission to outsmart cancer resistance' and 10x Genomics' chief executive.
| Company | Stage | Type | Cancers | Latest round |
|---|---|---|---|---|
| Mythic Therapeutics Waltham, MA, US | Wound down | biotech | Non-small-cell lung cancer | Series B 2021, $103M |
| Nested Therapeutics Cambridge, MA, US | Startup | biotech | Series A 2022, $90M | |
| Obsidian Therapeutics Cambridge, MA, US | Public | cell therapy | MelanomaNon-small-cell lung cancer | Crossover 2026, $350M |
| Tango Therapeutics Boston, MA, US | Public | biotech | Pancreatic ductal adenocarcinomaNon-small-cell lung cancerGlioma & glioblastoma | IPO 2021, $353M |
| Thyme Care Nashville, TN, US | Growth stage | cro services | Series E 2026, $125M |
Shares Obsidian Therapeutics, Tango Therapeutics and the tag vc.
Shares Thyme Care and the tag vc.
Shares Mythic Therapeutics and the tag vc.
Shares Mythic Therapeutics and the tag vc.
Shares Nested Therapeutics and the tag vc.
Shares Obsidian Therapeutics and the tag vc.
Shares Obsidian Therapeutics, Tango Therapeutics and the tag vc.
Shares Nested Therapeutics and the tag vc.